The high energy collisional activation project will develop fundamental technology to improve proteomics and lipidomics. The integration of genomic and proteomic data has revealed deficiencies in the sequence coverage of proteins that are identified using conventional proteomic methods. Specifically, a minority of high value genomic variants in cancer are currently identified by state-of-the-art proteomics. This work will deploy new methods using high energy collisional activation tandem mass spectrometry on a MALDI-ToF/ToF platform that is coupled to a two dimensional high performance liquid chromatograph. The ability of HE-CAD to promote pathways of fragmentation (charge-remote fragmentation) that are not currently being used in proteomics is aimed at identifying the proteins that are expressed.
The second aim i s to apply high energy collisional activation to complex lipids, particularly those from pathogenic microorganisms. The lipids and the biosynthetic pathways that generate them in microbes are very different from mammals and thus are a potential target for therapies.
-Public Health Relevance. The Washington University Biomedical Mass Spectrometry Resource has a longstanding history as an active and productive citizen in the NIH Biotechnology Research Resources community. We propose to extend our mission by advancing mass spectrometry technology, development, and research, applying these discoveries to answer critical biomedical research questions, and training the next generation of researchers, towards the ultimate goal of improving public health.
Showing the most recent 10 out of 323 publications
